An optimised lipid nanoparticle platform enables efficient CRISPR/Cas9 genome editing in hard-to-transfect cells

Journal:

Acta Biomaterialia

Published:

2026-05-28

DOI:

10.1016/j.actbio.2026.05.044

Affiliations:

6

Authors:

7

Go to article

Institutions	Authors	Share
University of Technology Sydney (UTS), Australia	3.000000	0.43
University of New South Wales (UNSW Sydney), Australia	1.000000	0.14
University of Tasmania (UTAS), Australia	1.000000	0.14
Beijing Ditan Hospital, Capital Medical University, China	1.000000	0.14
Chongqing Medical University (CQMU), China	0.500000	0.07
The First Affiliated Hospital of Chongqing Medical University, China	0.500000	0.07